Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Blood|September 12, 2022
The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemiaAdi Nagler, Catherine J WuNature Reviews. Cancer|February 2, 2022
Mechanisms of immune activation and regulation: lessons from melanomaShelly Kalaora, Adi Nagler, Jennifer A Wargo, et al.Anti-Cancer Drugs|August 14, 2012
Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factorEyal Zcharia, Ruth Atzmon, Adi Nagler, et al.The FEBS Journal|October 14, 2015
Inhibition of APOBEC3G activity impedes double-stranded DNA repairPonnandy Prabhu, Shivender M D Shandilya, Elena Britan-Rosich, et al.Oncotarget|August 23, 2018
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.Oncotarget|March 14, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.Genome Biology|April 16, 2026
Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.Nature Communications|January 3, 2024
Integrative genotyping of cancer and immune phenotypes by long-read sequencingLivius Penter, Mehdi Borji, Adi Nagler, et al.Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.Pageof 2